Results 171 to 176 of about 9,061 (176)

Abemaciclib/methylprednisolone

Reactions Weekly, 2021
openaire   +1 more source

Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3☆

Annals of Oncology
Shin Cheh Chen, I H Park, S Paluch-Shimon   +2 more
exaly  

TRADE: a phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR-positive/HER2-negative breast cancer☆

Annals of Oncology
Erica L Mayer, Nabihah Tayob, Leticia Varella   +2 more
exaly  

Abemaciclib: The Newest CDK4/6 Inhibitor for the Treatment of Breast Cancer

Annals of Pharmacotherapy, 2019
exaly  

Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation

Cancer Treatment Reviews
exaly  

Abemaciclib/Rosuvastatin

Reactions Weekly
openaire   +1 more source